These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Novel antibacterial active quinolone-fluoroquinolone conjugates and 2D-QSAR studies. Panda SS; Liaqat S; Girgis AS; Samir A; Hall CD; Katritzky AR Bioorg Med Chem Lett; 2015 Sep; 25(18):3816-21. PubMed ID: 26253630 [TBL] [Abstract][Full Text] [Related]
5. Rational choice of an oral beta-lactam antibiotic. Periti P J Chemother; 1997 Sep; 9 Suppl 4():1-23. PubMed ID: 9373786 [No Abstract] [Full Text] [Related]
6. Clinical impact of in vitro data with newer quinolones. Smith JT J Chemother; 1989 Jul; 1(4 Suppl):662-3. PubMed ID: 16312581 [No Abstract] [Full Text] [Related]
7. Conformationally constrained analogs of N-substituted piperazinylquinolones: synthesis and antibacterial activity of N-(2,3-dihydro-4-hydroxyimino-4H-1-benzopyran-3-yl)-piperazinylquinolones. Emami S; Foroumadi A; Samadi N; Faramarzi MA; Rajabalian S Arch Pharm (Weinheim); 2009 Jul; 342(7):405-11. PubMed ID: 19544301 [TBL] [Abstract][Full Text] [Related]
8. Interactions between 4-quinolone antibacterials and multivalent metal ions. Smith JT J Chemother; 1989 Jul; 1(4 Suppl):134-5. PubMed ID: 16312339 [No Abstract] [Full Text] [Related]
9. Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones. Foroumadi A; Emami S; Mehni M; Moshafi MH; Shafiee A Bioorg Med Chem Lett; 2005 Oct; 15(20):4536-9. PubMed ID: 16115766 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of the new quinolones: an overview. Garcia-Rodriguez JA J Chemother; 1989 Jul; 1(4 Suppl):136-8. PubMed ID: 16312340 [No Abstract] [Full Text] [Related]
11. [Mechanisms of antimicrobial resistance]. Hori S; Hiramatsu K Nihon Rinsho; 1994 Feb; 52(2):327-31. PubMed ID: 8126881 [TBL] [Abstract][Full Text] [Related]
12. Overcoming β-lactam resistance in Gram-negative pathogens. Bush K Future Med Chem; 2016 Jun; 8(9):921-4. PubMed ID: 27228233 [No Abstract] [Full Text] [Related]
13. The antimicrobial activity of sparfloxacin, a new quinolone. Paradelis AG; Delidou K; Grigoriadou A; Salpigides G; Pangalis A Drugs; 1995; 49 Suppl 2():238-9. PubMed ID: 8549316 [No Abstract] [Full Text] [Related]
14. Acquisition and horizontal diffusion of beta-lactam resistance among clinically relevant microorganisms. Navarro F Int Microbiol; 2006 Jun; 9(2):79-81. PubMed ID: 16835837 [No Abstract] [Full Text] [Related]
15. Discovery of novel antibacterials. Romesberg FE; Craney A Bioorg Med Chem; 2016 Dec; 24(24):6225-6226. PubMed ID: 27932231 [No Abstract] [Full Text] [Related]
17. Design and synthesis of bridged gamma-lactams as analogues of beta-lactam antibiotics. Aszodi J; Rowlands DA; Mauvais P; Collette P; Bonnefoy A; Lampilas M Bioorg Med Chem Lett; 2004 May; 14(10):2489-92. PubMed ID: 15109638 [TBL] [Abstract][Full Text] [Related]
18. Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens. Hu XE; Kim NK; Gray JL; Almstead JI; Seibel WL; Ledoussal B J Med Chem; 2003 Aug; 46(17):3655-61. PubMed ID: 12904069 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the antibacterial activity of lomefloxacin with that of other antibiotic/chemotherapeutic agents. Cuffini AM; Tullio V; Vaiani G; Carlone NA J Chemother; 1989 Jul; 1(4 Suppl):178-81. PubMed ID: 16312358 [No Abstract] [Full Text] [Related]
20. Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-methyl-3-methylaminopiperidin-1-yl)quinolones. Wan ZL; Chai Y; Liu ML; Guo HY; Sun LY Yao Xue Xue Bao; 2010 Jul; 45(7):860-8. PubMed ID: 20931783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]